PCBIS (Platform of Chemical Biology & ADME of Strasbourg)

Therapeutic Approaches: Biologics, Small Molecules, Stem Cells

Therapeutic Areas of Expertise: Cardiology, Immunology, Infectious Diseases, Metabolic Disorders, Neurological Disorders, Psychiatric Disorders, Pain, Rare diseases

Center/Program Highlights: The Platform of Integrative Chemical Biology of Strasbourg (PCBIS) gives access to High Throughput Screening (HTS), chemical libraries, target libraries and early ADME-Tox to academic and private laboratories

Starting from biological targets (cells, proteins, nucleic acids, ...), PCBIS is able to set up specific high throughput screening in accordance with the associated composed problem and then to making out at high throughput its chemical and/or natural libraries or the molecules furnished in respect to ISO 9001 Quality Management System. Moreover PCBIS performs early ADME-Tox study which is necessary to determine or to predict properties as early as possible to avoid failures and to limit costs in chemical synthesis, in vivo studies, formulation.

Sources of Funding: Federal/State, Disease Foundations, University, project grants


Institutional Affiliation(s): CNRS & University of Strasbourg

UMS 3286 CNRS - Université de Strasbourg
Pôle API - Boulevard Sébastien Brant
, 67412

Center/Program Start Date: 1997

Number of Employees: 13